Exact Mass: 394.0388
Exact Mass Matches: 394.0388
Found 154 metabolites which its exact mass value is equals to given mass value 394.0388
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diflufenican
CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5369; ORIGINAL_PRECURSOR_SCAN_NO 5368 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5374; ORIGINAL_PRECURSOR_SCAN_NO 5371 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5368; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5376; ORIGINAL_PRECURSOR_SCAN_NO 5375 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5337; ORIGINAL_PRECURSOR_SCAN_NO 5333 CONFIDENCE standard compound; INTERNAL_ID 4010 CONFIDENCE standard compound; INTERNAL_ID 2315 CONFIDENCE standard compound; INTERNAL_ID 8384
JNJ-7706621
Alilusem
Demethyltorosaflavone C
Hexsose + C5H10O3, 1phosphate
Annotation level-3
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
methyl 5-chloro-4-O-demethylbarbatate|metyl 5-chloro-4-O-demethylbarbatate
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
Daphnoretine Acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
7-O-acetyldaphnoretin
Origin: Plant, Coumarins
2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine
Gonyautoxin II
From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.
2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-(2,4-dichlorophenoxy)-N-[4-(morpholin-4-ylmethyl)phenyl]acetamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide
Uracil octosyl acid 5-phosphate
An N-glycosyl compound with formula C12H15N2O11P that is a common intermediate in the biosynthesis of nikkomycins and polyoxins by bacteria.
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone
N,N-diethyl-2-[(4-fluorophenyl)methylthio]-1,3-benzoxazole-5-sulfonamide
2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2,3-dideoxy-alpha-D-ribofuranos-5-yl group.
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
7-chloro-4-[(2-fluorophenyl)-oxomethyl]-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
3-(enolpyruvyl)uridine 5-monophosphate
A uridine 5-phosphate that is UMP in which the hydroxy hydrogen at position 3 has been replaced by an enolpyruvyl group.
ARN19874
ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].
M1002
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].